<DOC>
	<DOCNO>NCT02791217</DOCNO>
	<brief_summary>MiRNAs small ( ~19-25 nucleotide ) non-coding RNA molecule bind mRNA sequence-specific manner . MiRNAs regulate gene expression post-transcriptional level . MiRNAs regulate critical cell process metabolism , apoptosis , development , cell cycle , hematopoietic differentiation implicate development progression several type cancer , include hematological malignancy . Over-expression , amplification and/or deletion miRNAs miRNA-mediated modification epigenetic silence lead oncogenic pathway . Hematologic cancer , cause malignant transformation bone marrow cell lymphatic system , usually divide three major cluster : leukemia , lymphoma , multiple myeloma . To date , hematological malignancy aggressive early diagnosis essential improve prognosis increase survival rate . However , current diagnostic method various limitation , insufficient sensitivity , specificity , also time-consuming , costly , require high level expertise , limit application clinical context . Thus , development new biomarkers early detection relapse hematological malignancy desirable . Some innate property miRNAs make highly attractive potential biomarkers . MiRNAs readily detect small volume sample use specific sensitive quantitative real-time PCR ; isolate body fluid , include serum , plasma , urine , saliva , tear semen know circulate highly stable , cell-free form . They highly conserve specie , allow use animal model disease pre-clinical study . Furthermore , tumor cell show release miRNAs circulation profile miRNAs alter plasma and/or serum patient cancer . A grow number publication confirm miRNAs useful biomarker hematological malignancy diagnosis progression .</brief_summary>
	<brief_title>Identification Hematological Malignancies Therapy Predication Using microRNAs Diagnostic Tool</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Lymphoma , Follicular</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<criteria>Newly diagnose patient : Diffused large B cell lymphoma , Follicular lymphoma , Multiple myeloma Hodgkin lymphoma . Patients chemotherapy ( 530 day ) . Above age 18 . NonHIV/HCV/HBV Below age 18 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>